American Lung Association's "State of Lung Cancer" report reveals new national and state lung cancer data and calls on Congress to pass the Clinical Trial Modernization Act
CHICAGO, Nov. 17, 2026 /PRNewswire/ -- Today, the American Lung Association released its ninth annual "State of Lung Cancer" report, which shows the toll lung cancer takes on each state in the country. Lung cancer is the leading cause of cancer deaths in the U.S., with an estimated 229,410 people to be diagnosed this year.

The report finds that the lung cancer survival rate continues to improve. Advances in lung cancer research have led to dozens of new treatment options this year alone, while increased access to lung cancer screening helps detect the disease earlier, and expanded use of biomarker testing helps guide treatment decisions.
"Lung cancer is a devastating disease, but the positive trends detailed in our latest report offer hope. Since our first report only nine years ago, the national five-year survival rate has increased significantly, from 18.1% to 31.0%, and screening rates have also continued to rise. Unfortunately, not all communities have benefitted from this progress," said Harold Wimmer, President and CEO of the American Lung Association. "Awareness is still low and challenges remain. We must continue to drive progress on lung cancer screening, comprehensive biomarker testing, clinical trials and effective treatments to help people live longer, fuller lives after a lung cancer diagnosis."
Clinical trials are essential to improving outcomes for people affected by lung cancer and advancing research. Trials are used to evaluate new approaches to early detection and treatment that may be more effective. However, too many people face barriers that prevent them from participating in clinical trials. The American Lung Association is urging Congress to pass the Clinical Trial Modernization Act, which includes critical steps to make clinical trials accessible to more people and advance research and care for all.
The "State of Lung Cancer" report details national and state trends in the following key indicators:
The report also reveals differences in lung cancer outcomes among communities. Survival rates were highest for Asian and Pacific Islander individuals, Latino individuals and white individuals, who have survival rates of 35.4%, 30.8% and 30.8%, respectively; however, survival rates are significantly lower among Black individuals at 26.1% and Indigenous individuals at 18.2%, compared to white individuals. Overall, the report finds that people of color who are diagnosed with lung cancer are less likely to be diagnosed early, less likely to receive surgical treatment and more likely to receive no treatment.
There are a variety of risk factors associated with lung cancer, including smoking and exposure to radon gas, air pollution and secondhand smoke. Radon testing and mitigation, measures to limit air pollution, and reducing smoking rates through well-funded tobacco prevention and control programs, tobacco tax increases, smokefree air laws and access to comprehensive quit smoking services are all ways to help reduce the risk of lung cancer cases.
The American Lung Association brings research, advocacy and health promotions together to address lung cancer; investing in science, advocating for better access to prevention and care; and providing education, support and resources to help individuals navigate timely access to screening, diagnosis and treatment.
Learn more about the "State of Lung Cancer" report and take action to help end lung cancer at Lung.org/solc.
About the American Lung Association
The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy and research. The work of the American Lung Association is focused on four strategic imperatives: to defeat lung cancer; to champion clean air for all; to improve the quality of life for those with lung disease and their families; and to create a tobacco-free future. For more information about the American Lung Association, which has a 4-star rating from Charity Navigator and is a Platinum-Level GuideStar Member, call 1-800-LUNGUSA (1-800-586-4872) or visit: Lung.org. To support the work of the American Lung Association, find a local event at Lung.org/events.
CONTACT: Jill Dale | American Lung Association
P: 312-940-7001 E: Jill.Dale@Lung.org
View original content to download multimedia:https://www.prnewswire.com/news-releases/new-report-despite-gains-in-survivorship-and-screening-lung-cancer-remains-the-leading-cause-of-cancer-death-in-the-us-continued-research-and-improved-access-to-clinical-trials-are-critical-to-saving-more-lives-302941497.html
SOURCE American Lung Association